Literature DB >> 21713671

BTB-Kelch proteins and ubiquitination of kainate receptors.

John Marshall1, Leslie A C Blair, Jeffrey D Singer.   

Abstract

Kainate receptors (KAR) form a class of glutamate receptors that have been implicated in epilepsy, stroke, Alzheimer's and neuropathic pain.1 KAR subtypes are known to be segregated to specific locations within neurons and play significant roles in synaptic transmission and plasticity.2 Increasing evidence suggests a the role for ubiqutination in regulating the number of synaptic neurotransmitter receptors.3-5 The ubiquitin pathway consists of activation (E1), conjugation (E2) and ligation (E3). Cullins form the largest family of E3 ligase complexes. We have recently shown that the BTB/Kelch domain proteins, actinfilin and mayven, bind both Cul3 and specific KAR subtypes (GluR6 and GluR5-2b) to target these KARs for ubiquitination and degradation.5 In this chapter we will review how these interactions occur, what they mean for the stability of KARs and their associated proteins and how, in turn, they may affect synaptic functions in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21713671      PMCID: PMC3929045          DOI: 10.1007/978-1-4419-9557-5_10

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  62 in total

1.  The KA-2 subunit of excitatory amino acid receptors shows widespread expression in brain and forms ion channels with distantly related subunits.

Authors:  A Herb; N Burnashev; P Werner; B Sakmann; W Wisden; P H Seeburg
Journal:  Neuron       Date:  1992-04       Impact factor: 17.173

2.  Cloning of a novel glutamate receptor subunit, GluR5: expression in the nervous system during development.

Authors:  B Bettler; J Boulter; I Hermans-Borgmeyer; A O'Shea-Greenfield; E S Deneris; C Moll; U Borgmeyer; M Hollmann; S Heinemann
Journal:  Neuron       Date:  1990-11       Impact factor: 17.173

3.  Kainate receptor modulation of GABA release involves a metabotropic function.

Authors:  A Rodríguez-Moreno; J Lerma
Journal:  Neuron       Date:  1998-06       Impact factor: 17.173

4.  Rat GluR7 and a carboxy-terminal splice variant, GluR7b, are functional kainate receptor subunits with a low sensitivity to glutamate.

Authors:  H H Schiffer; G T Swanson; S F Heinemann
Journal:  Neuron       Date:  1997-11       Impact factor: 17.173

Review 5.  Kainate reveals its targets.

Authors:  J Lerma
Journal:  Neuron       Date:  1997-12       Impact factor: 17.173

6.  Kainate receptors mediate a slow postsynaptic current in hippocampal CA3 neurons.

Authors:  P E Castillo; R C Malenka; R A Nicoll
Journal:  Nature       Date:  1997-07-10       Impact factor: 49.962

7.  The synaptic activation of kainate receptors.

Authors:  M Vignes; G L Collingridge
Journal:  Nature       Date:  1997-07-10       Impact factor: 49.962

8.  kelch encodes a component of intercellular bridges in Drosophila egg chambers.

Authors:  F Xue; L Cooley
Journal:  Cell       Date:  1993-03-12       Impact factor: 41.582

9.  Modest loss of peripheral axons, muscle atrophy and formation of brain inclusions in mice with targeted deletion of gigaxonin exon 1.

Authors:  Florence Dequen; Pascale Bomont; Geneviève Gowing; Don W Cleveland; Jean-Pierre Julien
Journal:  J Neurochem       Date:  2008-07-31       Impact factor: 5.372

10.  Biochemical and assembly properties of GluR6 and KA2, two members of the kainate receptor family, determined with subunit-specific antibodies.

Authors:  R J Wenthold; V A Trumpy; W S Zhu; R S Petralia
Journal:  J Biol Chem       Date:  1994-01-14       Impact factor: 5.157

View more
  9 in total

Review 1.  Ubiquitination of neurotransmitter receptors and postsynaptic scaffolding proteins.

Authors:  Amy W Lin; Heng-Ye Man
Journal:  Neural Plast       Date:  2013-02-03       Impact factor: 3.599

2.  Mouse RC/BTB2, a member of the RCC1 superfamily, localizes to spermatid acrosomal vesicles.

Authors:  Jiannan Wang; Maria E Teves; Xuening Shen; David R Nagarkatti-Gude; Rex A Hess; Scott C Henderson; Jerome F Strauss; Zhibing Zhang
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

Review 3.  Historical perspective and progress on protein ubiquitination at glutamatergic synapses.

Authors:  Angela M Mabb
Journal:  Neuropharmacology       Date:  2021-06-29       Impact factor: 5.273

4.  Gene expression profile analysis in epilepsy by using the partial least squares method.

Authors:  Dong Wang; Xixiao Song; Yan Wang; Xia Li; Shanshan Jia; Zhijing Wang
Journal:  ScientificWorldJournal       Date:  2014-05-12

Review 5.  Kelch proteins: emerging roles in skeletal muscle development and diseases.

Authors:  Vandana A Gupta; Alan H Beggs
Journal:  Skelet Muscle       Date:  2014-06-01       Impact factor: 4.912

6.  KCTD10 is involved in the cardiovascular system and Notch signaling during early embryonic development.

Authors:  Kaiqun Ren; Jing Yuan; Manjun Yang; Xiang Gao; Xiaofeng Ding; Jianlin Zhou; Xingwang Hu; Jianguo Cao; Xiyun Deng; Shuanglin Xiang; Jian Zhang
Journal:  PLoS One       Date:  2014-11-17       Impact factor: 3.240

7.  The CUL3-KLHL3 E3 ligase complex mutated in Gordon's hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interaction.

Authors:  Akihito Ohta; Frances-Rose Schumacher; Youcef Mehellou; Clare Johnson; Axel Knebel; Thomas J Macartney; Nicola T Wood; Dario R Alessi; Thimo Kurz
Journal:  Biochem J       Date:  2013-04-01       Impact factor: 3.857

8.  Genome-wide association mapping for identification of quantitative trait loci for rectal temperature during heat stress in Holstein cattle.

Authors:  Serdal Dikmen; John B Cole; Daniel J Null; Peter J Hansen
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

9.  Novel Cul3 binding proteins function to remodel E3 ligase complexes.

Authors:  Wananit Wimuttisuk; Mark West; Brittney Davidge; Kebing Yu; Arthur Salomon; Jeffrey D Singer
Journal:  BMC Cell Biol       Date:  2014-07-10       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.